Get started
GENINUS INC.GENINUS INC.GENINUS INC.

GENINUS INC.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

389030 chart


Full chart

Key stats


Market capitalization
‪44.86 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−368 KRW
Net income (FY)
‪−12.27 B‬ KRW
Revenue (FY)
‪6.46 B‬ KRW
Shares float
‪22.58 M‬
Beta (1Y)
1.00

Employees


Employees (FY)
73
Change (1Y)
−22 −23.16%
Revenue / Employee (1Y)
‪88.43 M‬ KRW
Net income / Employee (1Y)
‪−168.13 M‬ KRW

About GENINUS INC.


Sector
Health Technology
Industry
Biotechnology
CEO
Woong-Yang Park
Website
kr-geninus.com
Headquarters
Seoul
Founded
2018
ISIN
KR7389030008
FIGI
BBG012PLRTX1
GENINUS, Inc. engages in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology and solutions. Its products include the following: CancerSCAN, an NGS cancer diagnosis service; LiquidSCAN, a liquid biopsy NGS test; Celinus, a single-cell genome analysis service; and HealthSCAN, a genetic testing service that tests innate genes to identify diseases that each person is vulnerable to. The company was founded on April 20, 2018 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 389030.

Frequently Asked Questions


The current price of 389030 is 1,534 KRW — it has increased by 14.05% in the past 24 hours. Watch GENINUS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENINUS INC. stocks are traded under the ticker 389030.
389030 stock has risen by 28.80% compared to the previous week, the month change is a 18.00% rise, over the last year GENINUS INC. has showed a −14.01% decrease.
389030 reached its all-time high on Nov 8, 2021 with the price of 6,483 KRW, and its all-time low was 1,080 KRW and was reached on Apr 9, 2025. View more price dynamics on 389030 chart.
See other stocks reaching their highest and lowest prices.
389030 stock is 27.78% volatile and has beta coefficient of 1.00. Track GENINUS INC. stock price on the chart and check out the list of the most volatile stocks — is GENINUS INC. there?
Today GENINUS INC. has the market capitalization of ‪44.86 B‬, it has increased by 5.47% over the last week.
Yes, you can track GENINUS INC. financials in yearly and quarterly reports right on TradingView.
389030 net income for the last quarter is ‪−3.56 B‬ KRW, while the quarter before that showed ‪−2.00 B‬ KRW of net income which accounts for −78.15% change. Track more GENINUS INC. financial stats to get the full picture.
No, 389030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 73 employees. See our rating of the largest employees — is GENINUS INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENINUS INC. EBITDA is ‪−9.55 B‬ KRW, and current EBITDA margin is −147.90%. See more stats in GENINUS INC. financial statements.
Like other stocks, 389030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENINUS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENINUS INC. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENINUS INC. stock shows the sell signal. See more of GENINUS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.